Top Markets
#1 Islamic Coin Islamic Coin +152.58%
#2 Bitway Bitway +44.01%
#3 Starpower Starpower +37.36%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +33.04%
#5 aelf aelf +28.00%
#6 Pons Pons +27.54%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.67%
#8 SkyAI SkyAI +19.06%
#9 Ocean Protocol Ocean Protocol +17.00%
#10 Bedrock Bedrock +16.63%
Coin of the day
Islamic Coin Islamic Coin
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Onco-Innovations Ltd. Onco-Innovations Ltd.

Onco-Innovations Ltd.

ONCO
Classement en actions #29549
Onco-Innovations Ltd. is a Canadian biotechnology company primarily focused on... Onco-Innovations Ltd. is a Canadian biotechnology company primarily focused on pioneering cancer research and developing oncology treatments. A significant offering in their portfolio is ONC010, a product specifically designed for use in cancer therapies. This enterprise was founded on September 16, 2021, and conducts its operations from its headquarters located in Calgary, Canada.
Prix de l'action
$0.47705898
Dernière synchronisation: 2026-07-15
Capitalisation boursière
$20.69M
Changement (1 jour)
3.17%
Changement (1 an)
-65.19%
Pays
CA
Échange Onco-Innovations Ltd. (ONCO)

Catégorie

Healthcare
Ratio P/B pour Onco-Innovations Ltd. (ONCO)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Onco-Innovations Ltd., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Onco-Innovations Ltd. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR